Treating cognitive deficits in multiple sclerosis: are we there yet?
Publication
, Journal Article
Doraiswamy, PM; Rao, SM
Published in: Neurology
November 9, 2004
Duke Scholars
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
November 9, 2004
Volume
63
Issue
9
Start / End Page
1552 / 1553
Location
United States
Related Subject Headings
- Piperidines
- Nootropic Agents
- Neurology & Neurosurgery
- Multiple Sclerosis
- Memory
- Indans
- Humans
- Donepezil
- Cognition Disorders
- Cholinesterase Inhibitors
Citation
APA
Chicago
ICMJE
MLA
NLM
Doraiswamy, P. M., & Rao, S. M. (2004). Treating cognitive deficits in multiple sclerosis: are we there yet? Neurology, 63(9), 1552–1553. https://doi.org/10.1212/01.wnl.0000146628.30692.15
Doraiswamy, P Murali, and Stephen M. Rao. “Treating cognitive deficits in multiple sclerosis: are we there yet?” Neurology 63, no. 9 (November 9, 2004): 1552–53. https://doi.org/10.1212/01.wnl.0000146628.30692.15.
Doraiswamy PM, Rao SM. Treating cognitive deficits in multiple sclerosis: are we there yet? Neurology. 2004 Nov 9;63(9):1552–3.
Doraiswamy, P. Murali, and Stephen M. Rao. “Treating cognitive deficits in multiple sclerosis: are we there yet?” Neurology, vol. 63, no. 9, Nov. 2004, pp. 1552–53. Pubmed, doi:10.1212/01.wnl.0000146628.30692.15.
Doraiswamy PM, Rao SM. Treating cognitive deficits in multiple sclerosis: are we there yet? Neurology. 2004 Nov 9;63(9):1552–1553.
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
November 9, 2004
Volume
63
Issue
9
Start / End Page
1552 / 1553
Location
United States
Related Subject Headings
- Piperidines
- Nootropic Agents
- Neurology & Neurosurgery
- Multiple Sclerosis
- Memory
- Indans
- Humans
- Donepezil
- Cognition Disorders
- Cholinesterase Inhibitors